Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1672 1681 1686
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17693744 | Machine Learning for Somatic Single Nucleotide Variant Detection in Cell-free Tumor Nucleic acid Sequencing Applications | Final Rejection | GUARDANT HEALTH, INC. |
| 17407000 | METHODS AND SYSTEMS FOR DETERMINING THE CELLULAR ORIGIN OF CELL-FREE DNA | Non-Final OA | GUARDANT HEALTH, INC. |
| 19340724 | PLATFORMS, SYSTEMS, AND METHODS FOR MULTI-OBJECTIVE OPTIMIZATION AND COMPARATIVE ANALYSIS FOR SYNTHETIC BIOLOGY DEVELOPMENT | Non-Final OA | X Development LLC |
| 17535474 | METHOD OF DETERMINING CONTINUOUS DRUG DOSE USING REINFORCEMENT LEARNING AND PHARMACOKINETIC-PHARMACODYNAMIC MODELS | Non-Final OA | POSTECH Research and Business Development Foundation |
| 17247510 | Real-World Evidence of Diagnostic Testing and Treatment Patterns in U.S. Breast Cancer Patients with Implications for Treatment Biomarkers from RNA-Sequencing Data | Non-Final OA | TEMPUS AI. INC. |
| 17805656 | METHODS OF DETERMINING TISSUES AND/OR CELL TYPES GIVING RISE TO CELL-FREE DNA, AND METHODS OF IDENTIFYING A DISEASE OR DISORDER USING SAME | Non-Final OA | UNIVERSITY OF WASHINGTON |
| 17552326 | METHODS AND SYSTEMS FOR DETERMINING HAPLOTYPES AND PHASING OF HAPLOTYPES | Non-Final OA | ILLUMINA CAMBRIDGE LIMITED |
| 18878969 | DISCOVERY SYSTEM FOR CANDIDATES BASED ON TARGET PROTEIN STRUCTURES AND ITS OPERATION METHOD | Final Rejection | CALICI CO., LTD. |
| 18951277 | METHODS FOR IDENTIFYING POLYPEPTIDES | Final Rejection | Encodia, Inc. |
| 17550380 | method for classifying individuals in mixtures of DNA and its deep learning model | Non-Final OA | National Taiwan University |
| 17616626 | SYSTEMS AND METHODS FOR DIAGNOSTICS FOR BIOLOGICAL DISORDERS ASSOCIATED WITH PERIODIC VARIATIONS IN METAL METABOLISM | Non-Final OA | Icahn School of Medicine at Mount Sinai |
| 17548444 | TECHNIQUES FOR IDENTIFYING FOLLICULAR LYMPHOMA TYPES | Non-Final OA | BostonGene Corporation |
| 17403194 | ARTIFICIAL INTELLIGENCE ENGINE FOR GENERATING CANDIDATE DRUGS USING EXPERIMENTAL VALIDATION AND PEPTIDE DRUG OPTIMIZATION | Final Rejection | Peptilogics, Inc. |
| 17449734 | METHODS AND COMPOSITIONS FOR IMPUTING OR PREDICTING GENOTYPE OR PHENOTYPE | Final Rejection | PIONEER HI-BRED INTERNATIONAL, INC. |
| 17285325 | METHOD AND SYSTEM FOR CLAIM SCOPE LABELING, RETRIEVAL AND INFORMATION LABELING OF GENE SEQUENCE | Non-Final OA | Patsnap Limited |
| 17279277 | VACCINE POLYPEPTIDE COMPOSITIONS AND METHODS | Non-Final OA | Phoenix Children's Hospital, Inc. |
| 16869455 | DETECTING REPEAT EXPANSIONS WITH SHORT READ SEQUENCING DATA | Final Rejection | Illumina Cambridge Ltd. |
| 16222798 | Systems and Methods For RNA Analysis In Functional Confirmation Of Cancer Mutations | Non-Final OA | Five3 Genomics, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy